Let me make it simple. Epic, who is half Elite's BOD and chief scientific officer is buying shares of Elite. 6 million shares to fund trials. And these warrants have existed for a long time.
Already accounted for in fully diluted. You might have missed the two questions posed. Obviously Epic is funding Elite with the warrant conversions...which is much better then adding new shares and dilution not previously accounted for.
Like I said, I hope they convert all their warrants because it means they obviously see a bright future!!!
Trials for abuse resistant products in a 20 billion dollar market Can you answer the question regarding the studies or the IMS revenue number for the products about to launch? Its just a number and name some possible products. So can you answer?
Market Data 
Markets 
